Free Trial

TD Asset Management Inc Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

Error: One or more errors occurred.

TD Asset Management Inc lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.7% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,333,797 shares of the healthcare conglomerate's stock after selling 879,394 shares during the period. TD Asset Management Inc owned 0.15% of UnitedHealth Group worth $698,576,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Financial Management Professionals Inc. lifted its position in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after acquiring an additional 17 shares during the last quarter. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC lifted its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after acquiring an additional 21 shares during the last quarter. Retirement Planning Group LLC raised its position in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after buying an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group raised its position in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on UNH. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Wolfe Research reduced their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Finally, TD Securities reissued a "hold" rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $392.29.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $14.24 during mid-day trading on Tuesday, hitting $267.88. 25,033,751 shares of the stock were exchanged, compared to its average volume of 11,481,834. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a 50-day simple moving average of $300.91 and a 200 day simple moving average of $422.56. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $243.00 billion, a P/E ratio of 11.21, a P/E/G ratio of 1.39 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the prior year, the firm posted $6.80 EPS. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 in the last three months. Insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines